Liang Wang

12.4k total citations · 2 hit papers
190 papers, 7.1k citations indexed

About

Liang Wang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Liang Wang has authored 190 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Molecular Biology, 102 papers in Cancer Research and 53 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Liang Wang's work include Cancer-related molecular mechanisms research (43 papers), Prostate Cancer Treatment and Research (40 papers) and MicroRNA in disease regulation (37 papers). Liang Wang is often cited by papers focused on Cancer-related molecular mechanisms research (43 papers), Prostate Cancer Treatment and Research (40 papers) and MicroRNA in disease regulation (37 papers). Liang Wang collaborates with scholars based in United States, China and Finland. Liang Wang's co-authors include Stephen N. Thibodeau, Meijun Du, Xiaoyi Huang, Rachel L. Dittmar, Manish Kohli, Lisa A. Boardman, Tiezheng Yuan, Meihua Liang, Julie M. Cunningham and Jiangwei Liu and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Liang Wang

180 papers receiving 7.0k citations

Hit Papers

Surface chromium on Terracotta Army bronze wea... 2013 2026 2017 2021 2019 2013 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Surface chromium on Terracotta Army bronze weapons is neither an ancient anti-rust treatment nor the reason for their good preservation
    2019 1.0k citations Liang Wang et al. profile →
  2. Characterization of human plasma-derived exosomal RNAs by deep sequencing
    2013 846 citations Stephen N. Thibodeau, Liang Wang et al. profile →

Peers

Liang Wang
Zhengdong Zhang China
Masatoshi Watanabe Japan
Yunlong Liu United States
Mo Chen China
Hidekazu Takahashi Japan
Michael J. Atkinson Germany
Jianxun Wang China
Wei Dai United States
Li Zhan China
Zhengdong Zhang China
Liang Wang
Citations per year, relative to Liang Wang Liang Wang (= 1×) peers Zhengdong Zhang

Countries citing papers authored by Liang Wang

Since Specialization
Citations

This map shows the geographic impact of Liang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Wang more than expected).

Fields of papers citing papers by Liang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Wang. The network helps show where Liang Wang may publish in the future.

Co-authorship network of co-authors of Liang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Liang Wang. A scholar is included among the top collaborators of Liang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang Wang. Liang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Qi, et al.. (2025). Metabolic reprogramming in cholangiocarcinoma cancer stem cells: Emerging therapeutic paradigms. Cancer Letters. 622. 217714–217714. 1 indexed citations
3.
McCluskey, Braedan M., Scott Johnson, Kenneth Jacobsohn, et al.. (2024). Stat5 induces androgen receptor ( AR ) gene transcription in prostate cancer and offers a druggable pathway to target AR signaling. Science Advances. 10(9). eadi2742–eadi2742. 4 indexed citations
4.
Tian, Yijun, Dandan Dong, Zixian Wang, et al.. (2023). Combined CRISPRi and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of RUVBL1 and prostate cancer progression. The American Journal of Human Genetics. 110(8). 1289–1303. 6 indexed citations
5.
Rose, Kyle, Joshua J. Meeks, Bishoy M. Faltas, et al.. (2023). Circulating and urinary tumour DNA in urothelial carcinoma — upper tract, lower tract and metastatic disease. Nature Reviews Urology. 20(7). 406–419. 27 indexed citations
6.
Patel, Krupal, Tapan Padhya, Jinyong Huang, et al.. (2023). Plasma cell‐free DNA methylome profiling in pre‐ and post‐surgery oral cavity squamous cell carcinoma. Molecular Carcinogenesis. 62(4). 493–502. 9 indexed citations
7.
Rose, Kyle, Joshua J. Meeks, Bishoy M. Faltas, et al.. (2023). Author Correction: Circulating and urinary tumour DNA in urothelial carcinoma — upper tract, lower tract and metastatic disease. Nature Reviews Urology. 20(7). 452–452. 2 indexed citations
8.
Tian, Yijun, Paul A. Stewart, Yury O. Núñez López, et al.. (2023). Detectable Lipidomes and Metabolomes by Different Plasma Exosome Isolation Methods in Healthy Controls and Patients with Advanced Prostate and Lung Cancer. International Journal of Molecular Sciences. 24(3). 1830–1830. 8 indexed citations
9.
Wang, Liang, Jian Chen, Juan Yao, et al.. (2022). Atractylenolide III Attenuates Apoptosis in H9c2 Cells by Inhibiting Endoplasmic Reticulum Stress through the GRP78/PERK/CHOP Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2022. 1–12. 10 indexed citations
10.
Huang, Jinyong, Mingxiang Teng, İbrahim Halil Şahin, et al.. (2021). Cancer Detection and Classification by CpG Island Hypermethylation Signatures in Plasma Cell-Free DNA. Cancers. 13(22). 5611–5611. 11 indexed citations
11.
Wu, Chong, Jingjing Zhu, Xiaoran Tong, et al.. (2021). Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi‐phased study of prostate cancer. Cancer Communications. 41(12). 1387–1397. 8 indexed citations
12.
Liu, Duo, Jingjing Zhu, Dan Zhou, et al.. (2021). A transcriptome‐wide association study identifies novel candidate susceptibility genes for prostate cancer risk. International Journal of Cancer. 150(1). 80–90. 18 indexed citations
13.
Tian, Yijun, Qian Liu, Shengnan Yu, et al.. (2020). NRF2-Driven KEAP1 Transcription in Human Lung Cancer. Molecular Cancer Research. 18(10). 1465–1476. 11 indexed citations
14.
15.
16.
DeRycke, Melissa S., Melissa C. Larson, Asha Nair, et al.. (2019). An expanded variant list and assembly annotation identifies multiple novel coding and noncoding genes for prostate cancer risk using a normal prostate tissue eQTL data set. PLoS ONE. 14(4). e0214588–e0214588. 3 indexed citations
17.
Sipeky, Csilla, Ping Gao, Qin Zhang, et al.. (2018). Synergistic Interaction of HOXB13 and CIP2A Predisposes to Aggressive Prostate Cancer. Clinical Cancer Research. 24(24). 6265–6276. 21 indexed citations
18.
Bi, Xiuli, Xin Song, Nicole M. Pohl, et al.. (2013). A sequence variant in the phospholipase C epsilon C2 domain is associated with esophageal carcinoma and esophagitis. Molecular Carcinogenesis. 52(S1). 80–86. 14 indexed citations
19.
Xia, Pu, Yuanqing Ye, Margaret R. Spitz, et al.. (2012). Predictors of Survival in Never-Smokers with Non–Small Cell Lung Cancer: A Large-Scale, Two-Phase Genetic Study. Clinical Cancer Research. 18(21). 5983–5991. 11 indexed citations
20.
Wang, Liang, Hui Tang, Venugopal Thayanithy, et al.. (2009). Gene Networks and microRNAs Implicated in Aggressive Prostate Cancer. Cancer Research. 69(24). 9490–9497. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhengdong Zhang Breakdown of academic impact, for papers by Masatoshi Watanabe Breakdown of academic impact, for papers by Yunlong Liu Breakdown of academic impact, for papers by Mo Chen Breakdown of academic impact, for papers by Hidekazu Takahashi Breakdown of academic impact, for papers by Michael J. Atkinson Breakdown of academic impact, for papers by Jianxun Wang Breakdown of academic impact, for papers by Wei Dai Breakdown of academic impact, for papers by Li Zhan
Rankless by CCL
2026